tailoring neoadjuvant and adjuvant therapy in tnbc
Published 3 years ago • 133 plays • Length 2:16Download video MP4
Download video MP3
Similar videos
-
3:12
neoadjuvant versus adjuvant therapy in tnbc
-
5:21
optimal neoadjuvant and adjuvant therapy for patients with early tnbc
-
2:52
neoadjuvant and adjuvant therapy in triple negative breast cancer
-
1:02
evaluating the role of neoadjuvant chemotherapy and surgery in stage i tnbc
-
2:05
treatment advances in tnbc
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
2:36
tailoring medicine in breast cancer
-
1:42
the case for neoadjuvant pembrolizumab in tnbc
-
1:51
optimal chemotherapy combinations in tnbc gbrca subtypes
-
0:58
personalizing approaches in early-stage tnbc
-
1:22
immunological signatures to predict outcomes in patients with tnbc
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:58
targeted therapy in tnbc
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
3:28
immunotherapy in early-stage tnbc - where do we stand?
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
1:36
dr. carey on tailoring treatment in triple-negative breast cancer
-
0:56
pembrolizumab as adjuvant therapy for tnbc